IPO registrations (S-1, F-1) · Registrants

COGNITION THERAPEUTICS INC

SEC CIK
1455365 · filings on EDGAR ↗
Former names
COGNITION THERAPUTICS INC (2009–2010)
Registration
Form S-1, first filed 2021-07-19, last 2022-11-07; 2 initial registrations, 4 amendments
Outcome
Final prospectus filed 2021-10-12; declared effective 2021-10-07
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
2500 WESTCHESTER AVE, Purchase, NY 10577
Ticker
CGTX (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
COGNITION THERAPEUTICS INC on the corporate pages

Offering terms

Proposed price range
$11.00–$13.00 per share (S-1/A filed 2021-10-04)
Final price
$12.00 per share, within the range (424B4 filed 2021-10-12, an initial public offering)
Shares sold
3,768,116
Gross proceeds
$45,217,392 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CGTX
Lead underwriters
B. Riley Securities (2,499,275 shares)
Syndicate
Oppenheimer (1,318,841)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2021-07-19S-1S-1 (registration)COGNITION THERAPEUTICS INC0001104659-21-093246 ↗
2021-07-29S-1/AS-1/A (amendment)COGNITION THERAPEUTICS INC0001104659-21-097621 ↗
2021-08-20S-1/AS-1/A (amendment)COGNITION THERAPEUTICS INC0001104659-21-108070 ↗
2021-09-10S-1/AS-1/A (amendment)COGNITION THERAPEUTICS INC0001104659-21-114520 ↗
2021-10-04S-1/AS-1/A (amendment)COGNITION THERAPEUTICS INC0001104659-21-122299 ↗
2021-10-07S-1MEFS-1MEF (added securities)COGNITION THERAPEUTICS INC0001104659-21-124325 ↗
2021-10-07EFFECTEFFECT (declared effective)COGNITION THERAPEUTICS INC9999999995-21-003810 ↗
2021-10-12424B4424B4 (final prospectus)COGNITION THERAPEUTICS INC0001104659-21-125316 ↗
2022-11-07S-1S-1 (registration)COGNITION THERAPEUTICS INC0001104659-22-115489 ↗
2022-11-09EFFECTEFFECT (declared effective)COGNITION THERAPEUTICS INC9999999995-22-003250 ↗
2022-11-14424B4424B4 (final prospectus)COGNITION THERAPEUTICS INC0001104659-22-117372 ↗
2023-01-03EFFECTEFFECT (declared effective)COGNITION THERAPEUTICS INC9999999995-23-000027 ↗
2024-01-08424B4424B4 (final prospectus)COGNITION THERAPEUTICS INC0001104659-24-002241 ↗
2024-01-08EFFECTEFFECT (declared effective)COGNITION THERAPEUTICS INC9999999995-24-000062 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-10-04S-1/Aregistration statement$11.00–$13.003,350,000-Nasdaq CGTX2primary document; range, shares headline, cover names 2document ↗
2021-10-12424B4final prospectus$12.003,768,116$45,217,392Nasdaq CGTX2primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BIOS Memory SPV I, LPDirector,TenPercentOwner; TenPercentOwner122021–2026
Breedlove Mark H.Director22021
Fletcher Aaron G.L.Director; Director,TenPercentOwner162021–2026
Golden Seeds Cognition Therapeutics LLCTenPercentOwner32021–2022
Khattar Jack A.Director72021–2026
Monia Brett PDirector72021–2026
O'Brien James MichaelOfficerChief Financial Officer42021–2022
Ogden CAP Associates, LLCTenPercentOwner22021
Ricciardi LisaDirector,OfficerCEO & President172021–2026
Wallace PeggyDirector102021–2026
RICHSTONE ELLEN BDirector92021–2026person page Fuzzy
Caggiano AnthonyOfficerChief Medical Officer132021–2026
BIOS Advisors GP, LLCDirector,TenPercentOwner; TenPercentOwner132022–2026
BIOS Capital Management, LPDirector,TenPercentOwner; TenPercentOwner132022–2026
BIOS Equity Partners III, LPDirector,TenPercentOwner; TenPercentOwner92022–2025
Bios Equity Partners II, LPDirector,TenPercentOwner; TenPercentOwner102022–2026
Bios Equity Partners, LPDirector,TenPercentOwner; TenPercentOwner132022–2026
BIOS Fund III, LPDirector,TenPercentOwner; TenPercentOwner92022–2025
BIOS Fund III NT, LPDirector,TenPercentOwner; TenPercentOwner92022–2025
BIOS Fund III QP, LPDirector,TenPercentOwner; TenPercentOwner92022–2025
BIOS Fund II, LPDirector,TenPercentOwner; TenPercentOwner102022–2026
BIOS Fund II NT, LPDirector,TenPercentOwner; TenPercentOwner92022–2025
BIOS Fund II QP, LPDirector,TenPercentOwner; TenPercentOwner102022–2026
BIOS Fund I, LPDirector,TenPercentOwner; TenPercentOwner102022–2026
BIOS Fund I QP, LPDirector,TenPercentOwner; TenPercentOwner102022–2026
BIOS Memory SPV II, LPDirector,TenPercentOwner; TenPercentOwner92022–2025
BP Directors, LPDirector,TenPercentOwner; Other42022–2025
Cavu Advisors, LLCDirector,TenPercentOwner; TenPercentOwner122022–2025
Cavu Management, LPDirector,TenPercentOwner; TenPercentOwner122022–2025
Kreis Leslie W.Director; Director,TenPercentOwner; TenPercentOwner112022–2025
Einhorn Andrew J.OfficerInterim CFO12022
Doyle John BrendanOfficerChief Financial Officer132023–2026
Bios Clinical Opportunity Fund, LPDirector,TenPercentOwner12023
Bios Equity COF, LPDirector,TenPercentOwner12023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2018-11-28COGNITION THERAPEUTICS INCBiotechnology$8,000,000$1,646,868281
2018-03-15COGNITION THERAPEUTICS INCBiotechnology$5,000,000$2,409,575311
2016-11-30COGNITION THERAPEUTICS INCBiotechnology$6,500,000$4,176,324502
2016-03-31COGNITION THERAPEUTICS INCBiotechnology$4,500,000$3,470,072411
2014-04-01COGNITION THERAPEUTICS INCBiotechnology$16,568,545$15,834,018563

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCOGNITION THERAPEUTICS, INC.NYState business registriesname and state
Federal award recipientCOGNITION THERAPEUTICS, INC.NYFederal spending (USAspending)name and state
Form D issuerCOGNITION THERAPEUTICS INCPAForm D private offeringsCIK (EXACT)
SEC filerCOGNITION THERAPEUTICS INCSEC filers (EDGAR)CIK (EXACT)
Person pageEllen B RichstonePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), NY first:

More with this interest.

In other datasets, the same topic (Health) in NY:

Interests: Biological Products, (No Diagnostic Substances) · Health